The impact of rituximab on kidney function is clinically highly significant given that 40%–50% of patients with ongoing nephrotic syndrome progress to ESKD at 10 years [ 18 ].
← all excerpts
Prospective study of the effect of rituximab on kidney function in membranous nephropathy.
1
—
—